Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
Not Applicable
Recruiting
- Conditions
- Tricuspid Regurgitation Functional
- First Posted Date
- 2021-05-18
- Last Posted Date
- 2021-11-30
- Lead Sponsor
- Cardiac Implants LLC
- Target Recruit Count
- 15
- Registration Number
- NCT04890821
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York, United States
First in Human Study of the DaVingi™ TR System in the Treatment of Patients With Functional Tricuspid Regurgitation
Not Applicable
- Conditions
- Functional Tricuspid Regurgitation (TR)
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-11-12
- Lead Sponsor
- Cardiac Implants LLC
- Target Recruit Count
- 15
- Registration Number
- NCT03700918
- Locations
- 🇨🇿
Na Homolce Hospital, Prague, Czechia
🇫🇷Hopital Bichat, Paris, France
🇫🇷Institut Mutualiste Montsouris, Paris, France
News
No news found